Go Pro
OTCMKTS:MAQAF

Atlas Arteria (MAQAF) Stock Price, News & Analysis

Atlas Arteria logo
$3.30 0.00 (0.00%)
As of 07/31/2026

About Atlas Arteria Stock (OTCMKTS:MAQAF)

Advanced

Key Stats

Today's Range
$3.30
$3.30
50-Day Range
$3.09
$4.09
52-Week Range
$2.69
$4.09
Volume
N/A
Average Volume
1,296 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
2.52%
Price Target
$4.75
Consensus Rating
Sell

Company Overview

Atlas Arteria (OTCMKTS: MAQAF) is a global toll road owner and operator specializing in the development, management and long-term investment of transport infrastructure. The company partners with governments and institutional investors to acquire, manage and optimise concession-based road assets, generating stable revenue streams through user fees and toll collections. Atlas Arteria focuses on enhancing traffic flow and safety through targeted capital improvements and operational efficiencies across its portfolio.

The company’s primary assets span North America, Europe and Australia. In the United States, Atlas Arteria holds interests in the Chicago Skyway concession and the Indiana Toll Road, both critical freight corridors in the Midwest. In Europe, the group owns a majority stake in the A4 motorway concession in Poland, which serves as a key east-west transit route. In Australia, the company is involved with the Westlink M7 in New South Wales, a major orbital motorway that alleviates congestion around Sydney.

Originally established as part of the Macquarie Infrastructure Group, Atlas Arteria was spun out in 2006 to create a dedicated listed vehicle for toll road investments. Since its inception, the company has pursued a strategy of selective acquisitions and active asset management, reinvesting toll revenues to upgrade roadway infrastructure and expand capacity. This disciplined approach underpins Atlas Arteria’s objective of delivering long-term, predictable cash flows to its shareholders.

Atlas Arteria is governed by an experienced board and executive team with deep expertise in infrastructure finance and operations. The company is led by Managing Director and Chief Executive Officer Jean-Baptiste Dehon, who oversees strategic growth initiatives and asset performance. Under the chairmanship of Helen Coonan, Atlas Arteria maintains a strong commitment to safety, environmental stewardship and stakeholder engagement across all regions it serves.

AI Generated. May Contain Errors.

Atlas Arteria Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
31st Percentile Overall Score

MAQAF MarketRank™: 

Atlas Arteria scored higher than 31% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Atlas Arteria has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.

  • Upside Potential

    Atlas Arteria has a consensus price target of $4.75, representing about 43.9% upside from its current price of $3.30.

  • Amount of Analyst Coverage

    Atlas Arteria has only been the subject of 1 research reports in the past 90 days.

  • Read more about Atlas Arteria's stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Atlas Arteria is -32.07, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Atlas Arteria is -32.07, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Read more about Atlas Arteria's valuation and earnings.
  • Percentage of Shares Shorted

  • Short Interest Ratio / Days to Cover

    Atlas Arteria has a short interest ratio ("days to cover") of 999.99, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Atlas Arteria has recently decreased by 76.35%, indicating that investor sentiment is improving significantly.
  • Dividend Leadership

    Atlas Arteria is a leading dividend payer. It pays a dividend yield of 5.02%, putting its dividend yield in the top 25% of dividend-paying stocks.

  • Dividend Growth

    Atlas Arteria does not have a long track record of dividend growth.

  • Read more about Atlas Arteria's dividend.
  • News Sentiment

    Atlas Arteria has a news sentiment score of 0.25. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.69 average news sentiment score of Industrials companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for Atlas Arteria this week, compared to 0 articles on an average week.
Receive MAQAF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Atlas Arteria and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

MAQAF Stock News Headlines

The end may be near for these iconic stocks
Marc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are triggering a historic wealth transfer already underway in 2026. Household names like Intuit (-57%), Boston Scientific (-49%), and Tractor Supply (-40%) are cratering, while lesser-known companies like Sandisk (+573%) and Rackspace (+444%) surge. Chaikin has identified specific stocks he believes investors should sell before they fall further - and the names may surprise you. He's also pinpointing a company tapped as Nvidia's self-driving partner and a potential AI megadeal that could split into three high-growth stocks. Stream his free presentation to get every buy and sell recommendation with no membership or credit card required.tc pixel
Citi Sticks to Their Hold Rating for Atlas Arteria (MAQAF)
See More Headlines

MAQAF Stock Analysis - Frequently Asked Questions

Atlas Arteria's stock was trading at $2.84 at the beginning of the year. Since then, MAQAF stock has increased by 16.2% and is now trading at $3.30.

Shares of MAQAF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Today
8/03/2026
Next Earnings (Estimated)
8/27/2026

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Infrastructure Operations
Sub-Industry
N/A
Current Symbol
OTCMKTS:MAQAF
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Price Target and Rating

High Price Target
$4.75
Low Price Target
$4.75
Potential Upside/Downside
+43.9%
Consensus Rating
Sell
Rating Score (0-4)
1.00
Research Coverage
1 Analysts

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report

This page (OTCMKTS:MAQAF) was last updated on 8/3/2026 by MarketBeat.com Staff.
From Our Partners